Technology
Health
Biotechnology
Neurocrine
$85.719876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$85.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.12 (-1.29%) Today
$0.00 (0.00%) As of 4:40 PM EDT after-hours
Why Robinhood?
You can buy or sell Neurocrine and other stocks, options, ETFs, and crypto commission-free!
About NBIX
Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. Read More The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.
Employees
585
Headquarters
San Diego, California
Founded
1992
Market Cap
7.93B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
532.86K
High Today
$87.38
Low Today
$85.20
Open Price
$87.00
Volume
541.36K
52 Week High
$126.98
52 Week Low
$64.72
Collections
Technology
Health
Biotechnology
Pharmaceutical
US
North America
Price Paid on Robinhood
0% Lower
Right Now
52 Week Low
$64.72
Average Price Paid
$86.09
52 Week High
$126.98
Analyst Ratings
84%
of 19 ratings
Buy
84%
Hold
16%
Sell
0%
NBIX Earnings
-$1.12
-$0.57
-$0.03
$0.52
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Jul 29, After Hours